Mednet Logo
HomePediatric Hematology/OncologyQuestion

For patients with Stage IIIB or IV HD flowing Bv-AVEPC with initial large mediastinal adenopathy, how can we avoid ISRT?

1
2 Answers
Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Children’s Wisconsin

It is true that on the clinical trial AHOD1331, patients who presented with large mediastinal adenopathy received radiation therapy as did patients who were slow early responders (Deauville 4 or 5 after two cycles of therapy). It is noteworthy that 3-year event-free survival was extremely high for a...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · University of Saskatchewan

Excellent question.

Dr. @Dr. First Last's answer above is informative particularly the remarkable rates of radiation with N-AVD of 0.4%, while maintaining excellent outcomes. That is a preferred approach compared to what I will say next.

The only addition I have: I had a patient with stage IIB with b...

Register or Sign In to see full answer

For patients with Stage IIIB or IV HD flowing Bv-AVEPC with initial large mediastinal adenopathy, how can we avoid ISRT? | Mednet